BioPharma Credit PLC (LON: BPCR)

BioPharma Credit Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Jun 30, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Net Income	109.36	108.45	182.31	84.96	89.14	122.33
Loss (Gain) From Sale of Assets	-	-	-	-	-9.46	-8.56
Loss (Gain) From Sale of Investments	28.95	23.95	-5.95	23.75	-	-
Other Operating Activities	0.01	0.01	0.03	0.02	-21.76	-
Change in Accounts Receivable	2.57	-0.48	-9.83	-9.8	16	5.76
Change in Accounts Payable	-0.47	-8.74	17.71	-2.49	-15.84	11.98
Operating Cash Flow	140.42	123.18	184.28	96.44	58.07	131.52
Operating Cash Flow Growth	-26.84%	-33.15%	91.09%	66.06%	-55.85%	95.90%
Investment in Securities	39.07	-1.66	48.19	-94.82	-47.47	-100.3
Investing Cash Flow	39.07	-1.66	48.19	-94.82	-47.47	-100.3
Issuance of Common Stock	-	-	-	-	-	0.47
Repurchase of Common Stock	-79.42	-17.22	-50.09	-	-0.06	-
Common Dividends Paid	-130.8	-68.95	-95.74	-96.17	-96.17	-96.18
Financing Cash Flow	-210.22	-106.99	-206.62	-100.16	-113.96	-98.15
Foreign Exchange Rate Adjustments	-0.01	-0.01	-0.03	-0.02	-0.01	-0.01
Net Cash Flow	-30.73	14.53	25.82	-98.56	-103.37	-66.93
Free Cash Flow	140.42	123.18	184.28	96.44	58.07	131.52
Free Cash Flow Growth	-26.84%	-33.15%	91.09%	66.06%	-55.85%	95.90%
Free Cash Flow Margin	102.97%	90.75%	84.47%	92.83%	52.78%	87.15%
Free Cash Flow Per Share	0.11	0.09	0.14	0.07	0.04	0.10
Cash Interest Paid	-	-	-	-	-	0
Levered Free Cash Flow	69.43	56.88	124.09	40.26	56.6	100.75
Unlevered Free Cash Flow	69.43	56.88	124.09	40.26	56.6	100.75
Change in Net Working Capital	-1.08	10.91	-10.13	12.85	-0.89	-24.29

Source: S&P Capital IQ. Standard template. Financial Sources.